We are Medivolve.
We seek out disruptive technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate remarkable risk-adjusted returns for investors.
What we do
Our team is built to search for challenges, develop solutions, and solve the crisis at hand through strategic investment of human and financial resources.
Vaccine Validation
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Orci nascetur massa risus ac elementum, mattis. Cras velit eget nisi, quis nullam hendrerit convallis turpis.
COVID-19 IgG Antibody Rapid Test
Rapid Antibody tests tell you instantly whether your body is ready to fight the virus. If you had a previous infection or the vaccine you should have COVID-19 antibodies that will help protect you against the virus.
Collection Site
Medivolve’s wholly-owned subsidiary Collection Sites, LLC continues to help consumers access its effective and convenient COVID-19 testing solution.Actionable Intelligence
Our advantage comes in the form of proprietary knowledge and experience.
Research team
Google Partner powered digital analytics
Investment team
with combined experience of 500-years +
Advisory board
providing wide spectrum of brilliant insight
Network
comprised of experts, specialists & thought leaders
Global team
of operational teams and organizations
Investment Philosophy
Speed Obsessed
Medivolve invests resources in developing and delivering solutions to challenges that requires velocity without compromise
Betterment Focused
Medivolve measures and monitors the return on investment to ensure metrics of betterment are achieved as the first investment-priority
Positive Performance
Medivolve mandates that following a purposeful return on investment bandwidth and focus is equally a positive return on investment of resources
Join Medivolve's Investor Mailing List Today
Stay up to date on the latest developments and breakthroughs.